01-08-2001 | Original Article
Modulation of the pharmacokinetics of endogenous plasma uridine by 5-(phenylthio)acyclouridine, a uridine phosphorylase inhibitor: implications for chemotherapy
Published in: Cancer Chemotherapy and Pharmacology | Issue 2/2001
Login to get access